首页> 外文期刊>ERJ Open Research >Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD
【24h】

Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD

机译:在住院的COPD急性加重患者中使用辅助心血管治疗

获取原文
           

摘要

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is one of the most frequent diagnoses in patients presenting with acute dyspnoea or respiratory failure. According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) document, it is defined clinically as acute worsening of respiratory symptoms that result in additional therapies, bronchodilators, corticosteroids and antibiotics being the cornerstone of acute management [1].In real-life practice, acute exacerbation of COPD is often treated as a cardiopulmonary syndrome http://ow.ly/uAnk30luMYz
机译:慢性阻塞性肺疾病(AECOPD)的急性加重是出现急性呼吸困难或呼吸衰竭的患者中最常见的诊断之一。根据全球慢性阻塞性肺疾病倡议(GOLD)文件,在临床上将其定义为呼吸道症状的急性恶化,导致进一步的治疗,支气管扩张剂,皮质类固醇和抗生素是急性治疗的基础[1]。实践中,COPD的急性加重通常被视为心肺综合征[http://ow.ly/uAnk30luMYz>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号